GGrantIndex
Sort

326,823 grants matching clinical trial

Advancing women’s care in Alzheimer’s disease and other dementias through EHR

$3,377,863
Sunghwan Sohn · Mayo Clinic Rochester · RF1 · FY2025 · AG

Data Management Core

$3,377,430
Jean Macdonald · Dana-Farber Cancer Inst · U10 · FY2025 · CA

Ibudilast Phase II trial in progressive MS

$3,376,514
Robert J. Fox · Cleveland Clinic Lerner Com-Cwru · U01 · FY2014 · NS

PROTON RADIATION THERAPY RESEARCH

$3,376,474
Massachusetts General Hospital · P01 · FY2003 · CA

Cardiovascular Gene Therapy Center

$3,376,374
University Of Pittsburgh At Pittsburgh · U01 · FY2005 · HL

BARI II: A TRIAL OF REVASC. &GLYCEMIC CONTROL IN NIDDM

$3,376,063
University Of Pittsburgh At Pittsburgh · U01 · FY2000 · HL

NCI Community Cancer Centers Program (NCCCP)

$3,376,000
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA

Non-invasive Neuromodulation Unit (NNU)

$3,375,712
Sarah Lisanby · National Institute Of Mental Health · ZIA · FY2019 · MH

The Indiana University-Ohio State University Maternal and Pediatric Precision in Therapeutics Data, Model, Knowledge, and Research Coordination Center (IU-OSU MPRINT DMKRCC)

$3,375,307
Sara K Quinney · Indiana University Indianapolis · P30 · FY2025 · HD

Neuropsychiatric Genome-Scale and RDOC Individualized Domains (N-GRID)

$3,375,284
Isaac S. Kohane · Harvard Medical School · P50 · FY2014 · MH

Global Health Comparative Effectiveness: A data synthesis method applied to HIV

$3,373,920
James Gustave Kahn · University Of California, San Francisco · RC4 · FY2010 · AI

Alphavirus Replicon Vaccines to Encephalitis Viruses

$3,373,441
Alphavax Human Vaccines, Inc. · U01 · FY2005 · AI

Buffalo Clinical and Translational Research Center

$3,373,083
Timothy F Murphy · State University Of New York At Buffalo · UL1 · FY2016 · TR

THE ZIMBABWE-SAN FRANCISCO HIV PREVENTION TRIALS UNIT

$3,372,937
University Of California San Francisco · U01 · FY2003 · AI

HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)

$3,372,423
Stephen A Spector · University Of California, San Diego · UM1 · FY2019 · AI

Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies

$3,371,715
Carsten Bonnemann · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS

Metabolic reprogramming of tumor microenvironment to maximize immunotherapy for pediatric cancers

$3,370,657
Ruoning Wang · Research Inst Nationwide Children'S Hosp · U01 · FY2018 · CA

Effects of AFQ056 on Language Learning in Young Children with Fragile X Syndrome (FXS)

$3,370,427
Elizabeth Mara Berry-Kravis · Rush University Medical Center · U01 · FY2017 · NS

Using SMART Design to Identify an Effective and Cost-Beneficial Approach to Preventing OUD in Justice-Involved Youth

$3,370,404
Kym R Ahrens · Seattle Children'S Hospital · UH3 · FY2021 · DA

University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)

$3,370,206
Joseph J. Eron · Univ Of North Carolina Chapel Hill · U01 · FY2009 · AI

DATA AND STATISTICS CENTER FOR THE NIDA CLINICAL TRIALS NETWORK

$3,368,894
Paul Vanveldhuisen · The Emmes Company, Llc · N01 · FY2013 · DA

The VITamin D and OmegA-3 TriaL (VITAL)

$3,368,726
Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2019 · CA

Cancer Immunotherapy Trials Network Central Operations and Statistical Center

$3,368,475
Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2012 · CA

HCMR Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

$3,367,487
Christopher M Kramer · University Of Virginia · U01 · FY2013 · HL

REPRIEVE - CCC - Lead Application

$3,367,267
Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2015 · HL